Evidence map›Paper›PMID 28003362›Full record

ArticleThe Journal of biological chemistry2017

Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP.

Maho Takahashi, Yanping Li, Tara J Dillon, Philip J S Stork

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Protein Kinase A in neurological disorders.Journal of neurodevelopmental disorders · 2024
    Review
  11. Signalling of Adrenoceptors: Canonical Pathways and New Paradigms.Handbook of experimental pharmacology · 2024
    Review
  12. Article
  13. Article
  14. Chemobrain: An accelerated aging process linking adenosine AInternational review of neurobiology · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Cancers · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Maho TakahashiFrom the Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239-3098.
Yanping LiFrom the Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239-3098.
Tara J DillonFrom the Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239-3098.
Philip J S StorkFrom the Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239-3098 stork@ohsu.edu.
Oregon Health & Science University · USVollum Institute · US

Funding

Training in the Molecular Basis of Skin/Mucosa PathobiologyT32CA106195 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI KULESZ-MARTIN, MOLLY F. · 2004 to 2018
$3.8M
Spatial control of cAMP signaling by EpacsR01DK090309 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI STORK, PHILIP J.S. · 2011 to 2014
$1.1M
Identifying new drug targets to block K-Ras/Raf in pancreatic cancer.R21CA191392 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI STORK, PHILIP J.S. · 2015 to 2016
$368k
NCI NIH HHS R21 CA191392NCI NIH HHS T32 CA106195NIDDK NIH HHS R01 DK090309
6 · The paper itself

Abstract

Cyclic adenosine monophosphate (cAMP) is an important mediator of hormonal stimulation of cell growth and differentiation through its activation of the extracellular signal-regulated kinase (ERK) cascade. Two small G proteins, Ras and Rap1 have been proposed to mediate this activation. Using HEK293 cells as a model system, we have recently shown that both Ras and Rap1 are required for cAMP signaling to ERKs. However, cAMP-dependent Ras signaling to ERKs is transient and rapidly terminated by PKA phosphorylation of the Raf isoforms C-Raf and B-Raf. In contrast, cAMP-dependent Rap1 signaling to ERKs and Rap1 is potentiated by PKA. We show that this is due to sustained binding of B-Raf to Rap1. One of the targets of PKA is Rap1 itself, directly phosphorylating Rap1a on serine 180 and Rap1b on serine 179. We show that these phosphorylations create potential binding sites for the adaptor protein 14-3-3 that links Rap1 to the scaffold protein KSR. These results suggest that Rap1 activation of ERKs requires PKA phosphorylation and KSR binding. Because KSR and B-Raf exist as heterodimers within the cell, this binding also brings B-Raf to Rap1, allowing Rap1 to couple to ERKs through B-Raf binding to Rap1 independently of its Ras-binding domain.

Indexed as

AnimalsCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHEK293 CellsHumansLysine-tRNA LigaseMiceMice, KnockoutProto-Oncogene Proteins B-rafrap GTP-Binding ProteinsBRAF protein, humanBraf protein, mouseCyclic AMPCyclic AMP-Dependent Protein KinasesExtracellular Signal-Regulated MAP KinasesKARS1 protein, humanLysine-tRNA LigaseProto-Oncogene Proteins B-rafrap GTP-Binding Proteins14-3-3 proteinextracellular-signal-regulated kinase (ERK)protein kinase A (PKA)Raf kinaseRas-related protein 1 (Rap1)

Identifiers

PMID28003362
PMCPMC5270487
OpenAlexW2562326542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.